3 ms·

And there's a fair bit of competition: Moderna, AstraZeneca, Johnson and Johnson, plus the 88 other ones in various stages of development: https://www.raps.org/

And there's a fair bit of competition: Moderna, AstraZeneca, Johnson and Johnson, plus the 88 other ones in various stages of development: https://www.raps.org/news-and-articles/news-articles/2020/3/covid-19-vaccine-tracker https://www.raps.org/news-and-articles/news-articles/2020/3/... If there were an easy route to a durable vaccine, I can't imagine that someone wouldn't have tried to take over that entire market instead of settling for a drip here and there. You could charge a lot more (see also: SMA and Hepatitis C treatments) and the value to the brand ("From the people who ended the pandemic...") would be amazing.

touisteur 5y ago
You're doing the Lord's work here and I'm here to say I regret I can't upvote you more. For all the permanent talk about Hanlon's Razor in here, it seems to all have gone out the window. As if there wouldn't be dozens of pharma researchers whistleblowing 'we have the cure but our lab won't sell it'. An annual vaccine is what mostly works for the flu, and nobody but cranks was talking about labs not really wanting to cure the flu. It's just so damn hard. Now everything is easy? they just decided not to save us?
- cromka 5y ago
  > As if there wouldn't be dozens of pharma researchers whistleblowing 'we have the cure but our lab won't sell it'. Precisely: lack of information is also an information. Such a simple, even beautiful way to look at things, yet so commonly ignored.